Long-term treatment of psychophrenic psychoses;Langzeittherapie der erkrankungen des schizophrenen formenkreises

Journal fur Neurologie, Neurochirurgie und Psychiatrie

Volumn 7, Issue 1, 2006, Pages 28-31

  Dantendorfer, K ^a   Swoboda, H ^b  

^a Psychosozialen Dienst Burgenland ^*  (Austria)

^b Sozialmedizinischen Zentrum Baumgartner Höhe   (Austria)

Author keywords

Compliance; Long term treatment; Relapse prevention; Schizophrenia

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; NEUROLEPTIC AGENT;

CHRONICITY; CLINICAL TRIAL; DIAGNOSTIC IMAGING; DRUG EFFECT; HUMAN; LONG TERM CARE; META ANALYSIS; MORPHOLOGY; NEUROPATHOLOGY; NEUROPROTECTION; PSYCHOSIS; PSYCHOSOCIAL CARE; RELAPSE; REVIEW; SCHIZOPHRENIA; SYSTEMATIC REVIEW;

EID: 33644800171     PISSN: 16081587     EISSN: 16809440     Source Type: Journal    
DOI: None     Document Type: Review

References (22)

1. Möller HJ. Course and long term treatment of schizophrenic psychoses. Pharmakopsychiatrie 2004; 37 (Suppl 2): 126-35.
2. Relapse Prevention in Schizophrenia Consensus Group. Towards consensus in the long-term management of relapse prevention in schizophrenia. Hum Psychopharmacol Clin Exp 2005; 20: 175-81.
3. Royal Australian College of Psychiatrists. Clinical practice guidelines for the treatment of schizophrenia. Aust N Z J Psychiatry 2005; 39: 1-30.
4. Fenton M. Course and outcome in schizophrenia. Curr Opinion Psychiatry 1997; 10: 40-8.
5. Jäger M, Bottlender R, Wegner U, Wittmannn J, Strauß A, Möller HJ. 15-Jahres-Katamnesen schizophrener Psychosen im Vergleich zu affektiven und schizoaffektiven Psychosen. In: Möller HJ (ed). Schizophrenie: Langzeitverlauf und Langzeittherapie. Springer, Wien, 2004.
6. Kraepelin E. Psychiatrie: ein Lehrbuch für Studierende und Aertzte. Barth-Verlag, Leipzig, 1896.
7. Meyer-Lindenberg AS, Olsen RK, Kohn PD, Brown T, Egan MF, Weinberger DR, Berman KF. Regionally specific disturbances of dorsolateral prefrontal- hippocampal functional connectivity in schizophrenia. Arch Gen Psychiatry 2005; 62: 379-86.
8. Lieberman JA, Chakos M, Wu H, Alvir J, Hoffman E, Robinson D, Bilder R. Longitudinal study of brain morphology in first episode schizophrenia. Biol Psychiatry 2001; 49: 487-99.
9. Andreasen NC, Nopoulos P, Arndt S, Magnotta V, Flaum M. Progressive structural brain abnormalities and their relationship to clinical outcome: a longitudinal magnetic resonance imaging study early in schizophrenia. Arch Gen Psychiatry 2003; 60: 585-94.
10. Seok JB, Soo KJ, Yoon KS, Lee C, Youn T, Moon CH, Yoon KC. Functional imaging evidence of the relationship between recurrent psychotic episodes and neurodegenerative course in schizophrenia. Psychiatry Res 2005; 139: 219-28.
11. Keshaven MS, Berger G, Zipursky RB, Wood SJ, Pantelis C. Neurobiology in early psychosis. Br J Psychiatry 2005; 48 (Suppl): S8-S18.
12. Shenton ME, Dickey CC, Frumin M, Mc Carley RW. A review of MRI findings in schizophrenia. Schizophr Res 2001; 49: 1-52.
13. Harrison PJ, Weinberger DR. Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Mol Psychiatry 2005; 10: 40-68.
14. Weinberger DR. Genetic mechanisms of psychosis: In vivo and post-mortem genomics. Clinical Therapeutics 2005; 27 (Suppl 1): S8-S15.
15. Lieberman JA, Tollefson GD, Charles C, Zipursky R, Sharma T, Kahn RS, Keefe RS, Green AL, Gur RE, Mc Evoy J, Perkins D, Hamer RM, Gu H, Tohen M. Antipsychotic drug effects on brain morphology in first-episode psychosis. Arch Gen Psychiatry 2005; 62: 361-70.
16. Möller HJ. Neuroleptische Langzeittherapie schizophrener Erkrankungen. In: Heinrich K (Hrsg). Leitlinien neuroleptischer Therapie. Springer, Wien, 1990.
17. Möller HJ, Bottlender R, Gross A, Hoff R, Wittmann J, Wegner U, Strauss A. The Kraepelinian dichotomy: preliminary results of a 15-year follow-up study on functional psychoses: focus on negative symptoms. Schizophr Res 2002; 56: 87-94.
18. Cheung HK. Schizophrenics fully remitted on neuroleptics for 3-5 years - to stop or continue drugs. Br J Psychiatry 1981; 138: 490-4.
19. Leucht S, Barnes TR, Kissling W, Engel RR, Correll C, Kane JM. Relapse prevention in schizophrenia with new antipsychotics: a meta-analysis of randomized controlled trials. Am J Psychiatry 2003; 160: 1209-22.
20. Kasper S (Hrsg). Schizophrenie: Medikamentöse Therapie, Konsensus-Statement. CliniCum 2002; Sonderausg. 11/2002.
21. Gaebel W. Is intermittent, early intervention medication an alternative for neuroleptic maintenance treatment? Int Clin Psychopharmacol 1995; 9: 11-6.
22. Jolley AG, Hirsch SR, Morrison E, Mc Rink A, Wilson L. Trial of brief intermittent neuroleptic prophylaxis for selected schizophrenic patients. Br Med J 1990; 301: 837-42.